Artificial Intelligence (AI) in Endoscopy Market Report 2025

The artificial intelligence (AI) in endoscopy market size has grown exponentially in recent years. It will grow from $10.53 billion in 2024 to $13.52 billion in 2025 at a compound annual growth rate (CAGR) of 28.4%. The growth observed during the historic period can be attributed to the growing adoption of minimally invasive procedures, rising prevalence of gastrointestinal disorders, increased focus on early cancer detection, expansion of digital health infrastructure, and rising healthcare spending in developed countries.

The artificial intelligence (AI) in endoscopy market size is expected to see exponential growth in the next few years. It will grow to $36.38 billion in 2029 at a compound annual growth rate (CAGR) of 28.1%. The growth during the forecast period can be attributed to rising demand for real-time lesion detection, increasing government support for artificial intelligence-based diagnostics, growing penetration of AI in hospitals and surgical centers, expansion of cloud-based healthcare analytics, and greater availability of AI-integrated endoscopy equipment. Major trends expected in this period include technological advancements in AI-powered imaging systems, ongoing research and development in computer vision, integration of augmented reality in endoscopy, innovations in cloud-based diagnostic platforms, and the development of AI-assisted robotic endoscopy.

The increasing prevalence of gastrointestinal diseases is expected to drive the growth of the artificial intelligence (AI) in endoscopy market in the coming years. Gastrointestinal diseases encompass various conditions affecting the digestive tract, causing symptoms such as abdominal pain, bloating, and changes in bowel habits. This rise is attributed to the growing consumption of ultra-processed foods, which disrupt the gut microbiota and lead to chronic inflammation and digestive problems. AI in endoscopy enhances the diagnosis of gastrointestinal diseases by accurately analyzing images in real time to identify abnormalities. It supports early intervention, reduces errors, and improves patient outcomes. For example, in December 2023, according to the IBD Registry, a UK-based non-profit organization, the number of individuals with inflammatory bowel disease (IBD) enrolled in the registry surpassed 5,300 in 2023, marking an increase of more than 3,000 compared to 2022. Thus, the rising prevalence of gastrointestinal diseases is fueling the AI in endoscopy market.

Key players in the artificial intelligence in endoscopy market are concentrating on developing advanced technologies such as AI-powered real-time lesion detection systems to improve clinical decision-making during gastrointestinal examinations. These AI-powered systems are sophisticated software tools that continuously analyze live endoscopic video streams to accurately detect and highlight suspicious lesions, including polyps and tumors, during procedures. For instance, in August 2024, Ainex Corporation, a Singapore-based medical technology firm, launched the Endoscopy AI system to boost real-time detection and diagnosis of gastrointestinal abnormalities during endoscopies. Integrated with advanced machine learning algorithms, it identifies gastrointestinal lesions during upper and lower endoscopy, enhancing diagnostic precision, reducing false positives, and improving visualization of mucosal abnormalities. This technology is designed to streamline clinical workflows, shorten procedure times, and enable earlier detection of gastrointestinal cancers and other diseases.

In June 2023, Olympus Corporation, a medical technology company based in Japan, acquired Odin Vision Ltd. for $77.47 million (£66 million). Through this acquisition, Olympus aims to accelerate its digital transformation in endoscopy by incorporating Odin Vision’s cloud-based AI solutions for real-time polyp detection and cancer diagnostics. This integration is expected to enhance clinical workflows, improve patient outcomes, and expand global access to advanced imaging technologies. Odin Vision Ltd. is a UK-based firm specializing in artificial intelligence technology for endoscopy.

Major players in the artificial intelligence (ai) in endoscopy market are Medtronic plc, Fujifilm Holdings Corporation, ASUSTeK Computer Inc., Olympus Corporation, Advantech Co. Ltd., Fraunhofer IIS, Iterative Health, CapsoVision Inc., EndoSoft Inc., Mauna Kea Technologies S.A., LPixel Inc., Sky Engine Limited, Wincomm Corporation, Endovision Limited, BioCam Sp. z o.o., Apex.AI Inc., MAIA Labs Inc., Magentiq Eye Ltd., EndoSurg.AI Inc., iEndoscopic GmbH, Intelliscopes LLC.

North America was the largest region in the artificial intelligence (AI) in endoscopy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) in endoscopy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the artificial intelligence (AI) in endoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) in endoscopy market consists of revenues earned by entities by providing services such as real-time image analysis, lesion detection and classification, polyp detection, procedural guidance, and diagnostic decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in endoscopy market includes sales of artificial intelligence integration endoscopy systems, artificial intelligence-powered decision support tools, artificial intelligence-enhanced video and image products, and artificial intelligence-enhanced light source systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified.)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The artificial intelligence (AI) in endoscopy market research report is one of a series of new reports that provides artificial intelligence (AI) in endoscopy market statistics, including the artificial intelligence (AI) in endoscopy industry global market size, regional shares, competitors with the artificial intelligence (AI) in endoscopy market share, detailed artificial intelligence (AI) in endoscopy market segments, market trends, opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in endoscopy industry. This artificial intelligence (AI) in endoscopy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Artificial intelligence (AI) in endoscopy involves the use of computer algorithms and machine learning techniques to support the detection, diagnosis, and classification of abnormalities during endoscopic procedures. It enhances clinical decision-making by offering real-time image analysis, improving accuracy, and reducing the likelihood of missed lesions.

The primary product types of artificial intelligence (AI) in endoscopy include AI-driven imaging systems, AI-powered endoscopic equipment, wearable endoscopy devices, consumables used in AI endoscopy, and software solutions for AI integration. AI-driven imaging systems are advanced diagnostic platforms that utilize AI algorithms to enhance endoscopic images, enabling automated abnormality detection and improved diagnostic accuracy for early disease identification. These systems offer functionalities such as image capture and processing, data management, enhanced visualization, real-time decision support, and training and simulation, and are applied across gastrointestinal, respiratory, urological, cardiovascular, and neurological endoscopy. The key end users comprise hospitals, diagnostic laboratories, outpatient surgical centers, research institutions, and specialized clinics.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.